Cargando…
DUSP1 induces apatinib resistance by activating the MAPK pathway in gastric cancer
Dual-specificity phosphatase-1 (DUSP1) is an oncogene that is associated with cancer progression following drug resistance. In order to investigate the potential relationship between DUSP1 and apatinib resistance in gastric cancer cells, we preformed many assays to study this problem. DUSP1 gene was...
Autores principales: | Teng, Fei, Xu, Zhiyuan, Chen, Jiahui, Zheng, Guowei, Zheng, Guodian, Lv, Hang, Wang, Yiping, Wang, Lijing, Cheng, Xiangdong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6072387/ https://www.ncbi.nlm.nih.gov/pubmed/29956792 http://dx.doi.org/10.3892/or.2018.6520 |
Ejemplares similares
-
Aqueous Huaier Extract Suppresses Gastric Cancer Metastasis and Epithelial to Mesenchymal Transition by Targeting Twist
por: Xu, Zhiyuan, et al.
Publicado: (2017) -
Apatinib enhances chemosensitivity of gastric cancer to paclitaxel and 5-fluorouracil
por: Xu, Zhiyuan, et al.
Publicado: (2019) -
Cisplatin resistance in gastric cancer cells is involved with GPR30‐mediated epithelial‐mesenchymal transition
por: Wang, Xiaofeng, et al.
Publicado: (2020) -
The SKA3-DUSP2 Axis Promotes Gastric Cancer Tumorigenesis and Epithelial-Mesenchymal Transition by Activating the MAPK/ERK Pathway
por: Zhang, Chao, et al.
Publicado: (2022) -
Siglec-15 Promotes Tumor Progression in Osteosarcoma via DUSP1/MAPK Pathway
por: Fan, Meng-ke, et al.
Publicado: (2021)